Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Meningococcal vaccine group B - GlaxoSmithKline

Drug Profile

Meningococcal vaccine group B - GlaxoSmithKline

Alternative Names: 4CMenB; Bexsero; Four component, meningococcal serogroup B vaccine (4CMenB) - GlaxoSmithKline; GSK-3536829A; MenB; MenB+OMV NZ - GlaxoSmithKline; Meningococcal B recombinant vaccine - GlaxoSmithKline; Multi-component meningococcal B vaccine (Bexsero) - GlaxoSmithKline; rMenB+OMV NZ

Latest Information Update: 08 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Norwegian Institute of Public Health; Novartis
  • Developer GlaxoSmithKline; Novartis
  • Class Meningococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Meningococcal group B infections

Most Recent Events

  • 03 Oct 2018 Updated efficacy and adverse events data from a phase IIIb trial in Meningococcal group B infections presented at the IDWeek 2018 (IDW-2018)
  • 27 Jul 2018 Phase-III clinical trials in Meningococcal group B infections (In infants) in USA (IM)(NCT03621670)
  • 28 Jun 2018 European Commission approves alternate dosing of meningococcal vaccine group B for Meningococcal group B infections (Prevention, In infants)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top